Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals Ownership Summary

Sonoma Pharmaceuticals is owned by 2.88% institutional investors, 0.42% insiders, and 96.70% retail investors. Citadel advisors is the largest institutional shareholder, holding 1.25% of SNOA shares. Fidelity Extended Market Index is the top mutual fund, with 0.44% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sonoma Pharmaceuticals	2.88%	0.42%	96.70%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Specialty & Generic Drug Manufacturers Stocks	37.12%	13.99%	48.89%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Citadel advisors	195.16K	1.25%	$41.41K
Geode capital management	19.94K	1.16%	$42.47K
Vanguard group	18.89K	1.15%	$68.75K
Mckinley carter wealth services	11.19K	0.65%	$23.84K
State street	24.32K	0.16%	$5.16K
Morgan stanley	2.00K	0.12%	$4.27K
Global retirement partners	772.00	0.05%	$2.81K
Rockefeller capital management	646.00	0.04%	$2.51K
Advisor group	500.00	0.03%	$1.06K
Blackrock	2.27K	0.01%	$481.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mckinley carter wealth services	11.19K	0.00%	$23.84K
Drw securities	-	-	-
Tower research capital llc (trc)	-	-	-
Blackrock	2.27K	-	$481.00
Heron bay capital management	-	-	-
Cwm	1.00	-	$2.00
Renaissance	-	-	-
Two sigma securities	-	-	-
Susquehanna group, llp	-	-	-
Rockefeller capital management	646.00	-	$2.51K

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	195.16K	-	195.16K
Geode capital management	19.94K	-	4.03K
Morgan stanley	2.00K	-	2.00K
Rockefeller capital management	646.00	-	646.00
Global retirement partners	772.00	-	334.00

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	-	-	-46.05K
Jane street group	-	-	-45.30K
Heron bay capital management	-	-	-33.78K
Xtx topco	-	-	-19.83K
Renaissance	-	-	-17.80K

New Positions

Holder	Shares	% Assets	Change	Value
Rockefeller capital management	646.00	-	646.00	$2.51K
Vanguard fiduciary trust	100.00	-	100.00	$213.00
Fmr	2.00	-	2.00	$7.00
Cwm	1.00	-	1.00	$2.00

Sold Out

Holder	Change
Sbi securities	-1.00
Caitong asset management	-1.00
Allworth financial lp	-3.00
Us bancorp \de\	-25.00
Jpmorgan chase	-123.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	14	-17.65%	110,782	64.20%	2	17.94%	6	-33.33%	1	-
Mar 31, 2026	11	-26.67%	43,767	-59.81%	2	6.32%	5	-	1	-80.00%
Dec 31, 2025	12	-36.84%	108,010	81.96%	6	50.15%	3	-72.73%	4	300.00%
Sep 30, 2025	18	63.64%	59,357	-30.08%	3	13.52%	12	140.00%	1	-50.00%
Jun 30, 2025	12	-	84,901	156.84%	5	101.48%	5	-	2	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	20.91K	0.44%	6.97K
Vanguard Institutional Extnd Mkt Idx Tr	18.79K	0.39%	-
Spartan Extended Market Index Pool E	2.97K	0.18%	2.92K
NT Ext Equity Mkt Index Fund - NL	3.20K	0.07%	3.19K
Fidelity Total Market Index	2.53K	0.05%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	2.32K	0.05%	2.31K
Fidelity Series Total Market Index	2.31K	0.05%	-
Spartan Total Market Index Pool G	1.04K	0.02%	-
Spartan Total Market Index Pool A1	1.04K	0.02%	-
Fidelity Nasdaq Composite Index	248.00	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 13, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.92K
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 09, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.68K
Mar 08, 2018	Schutz James J	Chief Executive Officer	Buy	$9.87K

Insider Transactions Trends

Date	Buy	Sell
2027 Q1	-	-
2026 Q1	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q2	-	-

SNOA Ownership FAQ

Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 2.88%, followed by 0.42% insiders and 96.70% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Citadel advisors (195.16K shares, 1.25%), Geode capital management (19.94K shares, 1.16%), and Vanguard group (18.89K shares, 1.15%). Together, they hold 3.56% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

Yes, BlackRock owns 0.01% of Sonoma Pharmaceuticals, totaling 2.27K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 481$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Mckinley carter wealth services is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 11.19K Sonoma Pharmaceuticals shares, valued at 23.84K$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 0.44% of its total shares outstanding invested in 20.91K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools